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Abstract. During a 2-year retrospective study, 195 non-HIV-infected patients with extrapulmonary tuberculosis
(EPT) were diagnosed at the National Tuberculosis Center, Kuala Lumpur, representing 10% of all patients with
tuberculosis. Their mean age was 39 (±SD) 14 years old (range 14-81). The largest age group was 25-34 years,
while 78.5% were less than 50 years of age. The subjects were mainly female (50.3%), Malay (49.2%), married
(61.5%), resided in Kuala Lumpur (51.0%), and were unemployed (50.3%). Regarding risk factors, they were
smokers and/or alcohol users (21.0%), and injecting drug users (IDUs) (5.1%); they also had history of tuberculosis
(3.6%) and contact with TB patients (9.2%). Lymphadenopathy was the most common sign (45.6%) shown in
the medical records. 42% of x-ray findings (chest, spine, and hip) showed signs consistent with tuberculosis,
while histopathology was the most useful diagnostic tool (52.3%) and lymph node was the most frequent specimen
used (35.0%) in this study. The three main sites of involvement were lymph nodes (42.6%), miliary and
disseminated (19.5%), and pleura (12.8%). The outcome of this study showed 72.8% of these patients had
completed treatment for at least 6 months, whilst, only 4.6% of patients were still undergoing treatment, and
unfortunately, 22.6% of them showed non-adherence to anti-tubercular therapy at a duration of less than 6 months.
However, no MDR-TB or death cases were reported or registered in this study.
studies on extrapulmonary tuberculosis in non HIV-
infected patients in the past two decades. Therefore,
we propose this study to identify the nature of
extrapulmonary tuberculosis in terms of its current
epidemiological pattern, clinical scenario, such as
manifestations, laboratories, diagnosis, the role of
treatment and most importantly its outcome among
non-HIV-infected patients, which definitely aids better
understanding and management of this resurgent
disease.
MATERIALS AND METHODS
From January 2001 to December 2002, we
retrospectively reviewed 1,903 patients with
tuberculosis who were registered at the National
Tuberculosis Center (NTBC), Kuala Lumpur,
Malaysia. Of these, 195 (10%) were diagnosed as
extrapulmonary tuberculosis. Their medical records
were reviewed according to our inclusion criteria for
study subjects, as follows; (1) HIV-negative patients
with anti-HIV status tested by any serological
technique, and age ≥ 14 years, (2) all patients who were
diagnosed as having developed tuberculosis of organs
other than the lungs eg pleura, lymph node, abdomen,
genito-urinary tract, skin, joints and bone, meninges,
etc. Diagnosis was based on one culture-positive
specimen, or histological or strong clinical evidence
consistent with active extra-pulmonary tuberculosis,
followed by a decision by a clinician to treat with a
full course of anti-tuberculosis chemotherapy (WHO,
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INTRODUCTION
Tuberculosis (TB) is an ancient killer disease that
can heavily affect both non-HIV and HIV-related
individuals. It remains a major challenge worldwide
both in terms of disease burden and resistance to
conventional antibiotic therapy (Eltringham and
Drobniewski, 1998). Tuberculosis is considered among
the top 5 communicable diseases reported in Malaysia
where the number has been constantly increasing from
12,691 (61%) in the year 1996 to 15,057 (64.7%) by
the end of the year 2000. The number of deaths seems
to be directly proportional to the nuber of cases, 271
(1.2%) in the year 1996, to 882 (4%) by the end of the
year 2000 (Ministry of Health, Malaysia, 2000). Data
before the Acquired Immune Deficiency Syndrome
(AIDS) era indicated that despite the decline in
pulmonary TB, the number of cases of extrapulmonary
tuberculosis remained constant (Noertjojo et al, 2002).
Extrapulmonary tuberculosis has a broad spectrum of
clinical manifestations that may be referable to almost
any organ system and should be considered in the
differential diagnosis of bone, joint, genitourinary tract
and central nervous system (CNS) disease (Alvarez
and McCabe, 1984). There have been surprisingly few
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2002). Throughout this study, socio-demographic
profiles, clinical presentations and investigation results,
treatment medications and duration, patient compliance
with therapy, and outcome of therapy response were
also enlisted in the standardized data collection sheet.
Multidrug resistant tuberculosis (MDR-TB) was
defined as resistance to at least 1 and/or 2 important
drugs, isoniazid (INH) and/or rifampicin (RF).
Defaulter was defined, in accordance with the World
Health Organization, as a patient who did not collect
medication for 2 months or more any time after
registration. The criteria for monitoring response to
treatment were improvement of clinical symptoms and
signs, x-ray or related laboratory findings when
compared to baseline, with compliance to therapy for
at least 6 months.
Statistical analysis
The data were analyzed using the statistical
software, SPSS version 10 (SPSS Inc, Chicago, USA).
Data with quantitative variables were expressed by
mean (±SD) and range, while qualitative variables were
estimated by frequency and percentage.
RESULTS
Table 1 illustrates the socio-demographic
characteristics of the study subjects at the time of
diagnosis. The mean age was 39 (±SD) 14 years (range
14-81). The largest age group was 25-34 years old,
and 78.5% were less than 50 years of age. Subjects
were mainly female (50.3%), the Malay (49.2%),
married (61.5%), resident in Kuala Lumpur (51.0%)
and unemployed (50.3%). Regarding risk factors, they
were smokers and/or alcohol users (21.0%), and
injecting drug users (IDUs) (5.1%), moreover, they also
had a history of previous tuberculosis (3.6%) and
contact with TB patients (9.2%).
At the time of diagnosis, 48.2 and 43.1% of patients
had positive BCG status and tuberculin skin test (≥ 10
mm), respectively. Lymphadenopathy was the most
common sign (45.6%) shown in the medical records;
33.3% was at the cervical, and 5.1% at the
supraclavicular regions. Forty-two percent of x-ray
findings included chest/miliary, spine and hip showed
signs consistent with tuberculosis, while histo-
pathological examination was the most useful tool
(52.3%) still routinely available for confirmation of
extrapulmonary tuberculosis, the lymph node was the
most frequent specimen used (35.0%) in this study, as
shown in Table 2.
Among 1,903 patients with tuberculosis, 195
(10%) non-HIV infected patients were diagnosed with
Table 1
Socio-demographic characteristics of 195 patients.
Variables No. of patients (%)
Range of age = 14-81 years
Mean ± SD = 39 ± 14 years
Sex ratio (M:F) = 1:1
Age group (year)
15-24 29 (15.0)
25-34 61 (31.3)
35-44 41 (21.0)
45-54 37 (19.0)
≥ 55 27 (13.8)
Sex
Male 97 (49.7)
Female 98 (50.3)
Race
Malay 96 (49.2)
Chinese 39 (20.0)
Indian 34 (17.4)
Othera 26 (13.3)
Marital status
Single 75 (38.5)
Married 120 (61.5)
Address
Kuala Lumpur 99 (51.0)
Outsider 96 (49.0)
Occupation
Laborer 47 (24.1)
Non-laborer 50 (25.6)
Unemployed 98 (50.3)
Determining factors
Smoking and/or alcohol 41 (21.0)
Intravenous drug user 10 (5.1)
Concomitant illness:
diabetes mellitus 9 (4.6)
Case category
New case 188 (96.4)
Relapse (previous history of
TB-lymph node or heart) 5 (2.6)
Return after default (previous
history of pulmonary TB) 2 (1.0)
History of contact with
tuberculosis patient 18 (9.2)
a Other: foreigners who were classified as persons with foreign
nationality and persons with first and/or family names that
were clearly not Malaysian.
extrapulmonary tuberculosis. Lymphatic, miliary/
disseminated, pleural and osteoarticular involvement
were the most common, as shown in Table 3. The result
of this study showed 72.8% of these patients completed
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Table 2
Clinical presentations and investigation results at
first entry.
Clinical presentations No. of patients (%)
Symptoms
Loss of appetite and weight 82 (42.1)
Cough 80 (41.0)
Fever 70 (36.0)
Pain (chest, loin, knee, hip, flank,
back, abdomen, and neck) 43 (22.1)
Sputum 35 (18.0)
Dyspnea 25 (13.0)
Hemoptysis 17 (8.7)
Dysphagia 1 (0.5)
Other 1 (0.5)
Signs
BCG vaccination status
Yes 94 (48.2)
No 51 (26.2)
No information 50 (25.6)
Tuberculin skin test
(Mantoux test)
≥ 10 mm 84 (43.1)
< 10 mm 29 (15.0)
No information 82 (42.1)
Lesion or swelling
(abscess or lump) 11 (5.6)
Hoarseness of voice 3 (1.5)
Hematuria 3 (1.5)
Blurring of vision 4 (2.0)
Lymphadenopathy 89 (45.6)
Cervical 65 (33.3)
Supraclavicular 10 (5.1)
Axilla or mediastinal 5 (2.5)
Mixed (at least 2 sites) 9 (4.6)
Investigation results
ESR
> 10 mm at the first hour 158 (81.0)
< 10 mm at the first hour 17 (8.7)
Not recorded 20 (10.3)
X-ray findings
Chest: not available 4 (2.1)
normal finding 108 (55.4)
abnormalities (pleural
effusion and parahilar cyst) 26 (13.3)
Miliary 38 (19.5)
Spine 15 (7.7)
Hip 3 (1.5)
Other results (CT scan, MRI, ultra-
sound, echocardiogram, PCR
and opthalmoscopic examination) 20 (10.3)
Sputum smear positive for AFB
Positive 12 (6.2)
Negative 167 (85.6)
No information 16 (8.2)
Sputum culture positive
for M. tuberculosis
Positive 20 (10.3)
Negative 151 (77.4)
No information 24 (12.3)
Fluid analysis (smear, culture
and biochemical analysis)
Positive 17 (8.7)
No information 178 (91.3)
Tissue biopsy 102 (52.3)
Positive 101 (51.8)
Lymph node 68 (35.0)
Pleura 9 (4.6)
Spine 5 (2.6)
Other 19 (9.7)
Negative 1 (0.5)
No information 94 (48.2)
treatment of at least 6 months, whilst only 4.6% of
patients were still undergoing treatment; 22.6% showed
non-adherence to anti-tubercular therapy at a duration
of less than 6 months. However, no MDR-TB or deaths
was reported or registered in this study, as illustrated
in Fig 1.
Lymph node tuberculosis
Tuberculous lymphadenitis was the most frequent
extrapulmonary tuberculosis in 83 (42.6%), with
predominant cervical lymph node involvement;
moreover, it was more common in females (M:F =
27:54) than males. The diagnosis of lymph node TB
was confirmed by typical histopathological
examination in 68 (82%) cases and by a high index of
suspicion of clinical s/s and/or positive tuberculin skin
test in 14 (17%) of cases. Seven (3.6%) patients were
still undergoing anti-tubercular therapy, but 13 (6.7%)
were lost to follow-up with no evidence of relevant
drug adverse reaction or resistance. Otherwise, all other
patients (included 4 relapse cases) completed treatment
of at least 6 months’ duration.
Miliary and disseminated tuberculosis
We found 38 (19.5%) patients, 36 had miliary
tuberculosis, miliary and TB-spine (1 case), and miliary
with TB-meninge, liver, and bone marrow (1 case).
All were diagnosed on the basis of clinical s/s and
radiological finding. Eleven, 18, and 9 patients were
confirmed bacteriologically by sputum smear for AFB,
culture for M. tuberculosis, or both, respectively. Only
1 case was diagnosed by cerebrospinal fluid for M.
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tuberculosis. Three out of 16 patients who were lost to
follow-up had adverse drug reactions in less than 6
months’ therapy. Another 22 (11.2%) patients
successfully completed treatment.
Pleural tuberculosis
Twenty-five (12.8%) patients with pleural
tuberculosis were notified in this study; definite
diagnoses (pleural biopsy and/or fluid analysis) were
made in 20, and presumptive diagnoses (s/s and CXR
finding) were made in 5. In the duration of less than 6
months’ therapy, 1 (0.5%) out of 4 patients who
defaulted during therapy had developed adverse drug
reaction, while only 1 patient in this category was still
undergoing treatment.  It is interesting to mention that
20 patients responded well to standard ATT.
Osteoarticular (bone-joint) tuberculosis
In 24 (12.3%) patients, spinal tuberculosis 20
(10.3%) was the most common extrapulmonary
tuberculosis, followed by the hip joint (3; 1.5%) and
knee joint (1; 0.5%).  Equal sex distribution was
observed in these patients. Most of TB-bone/joint cases
came with the presenting symptom of pain, back, hip,
knee and neck (19 patients), weakness (3 patients), and
paresthesia (2 patients). Eight patient diagnoses were
confirmed by histological examination, and 16 cases
were diagnosed by clinical s/s and/or radiological
imaging (x-ray, CT scan, or MRI).  Only 5 (2.6%) were
lost to follow-up and 1 of them developed drug-induced
hepatitis. Nineteen (including 2 patients who returned
after defaulting) completed treatment of at least 6
months, and interestingly, more than half of patients
11/19 (58%) were treated for at least 1 year with ATT.
Genito-urinary tuberculosis
There were 8 cases of genito-urinary tuberculosis;
bladder (4 cases), testes/epididymis (2), kidney (1),
and ovary (1). Definite diagnoses were made by
histological examination and/or fluid analysis in 6
cases, while 2 cases were diagnosed by clinical s/s and/
or ultrasound. Seven patients effectively responded
well to therapy, and only 1 patient defaulted treatment.
Abdominal tuberculosis
Out of 6 cases, tuberculous peritonitis was the most
common (4 cases), followed by intestine (1) and liver
(1). Definite diagnoses (tissue biopsy and/or fluid
analysis) were made in 5 cases and only 1 case was
diagnosed on the grounds of high clinical suspicion.
Four patients were successfully treated with ATT, while
2 cases were lost to follow-up.
Others
Twelve cases (6.2%) developed other forms of
extrapulmonary tuberculosis: eye (4 cases), skin (4),
heart (2), skeletal muscle (1), and breast (1). Half of
the cases were confirmed by tissue biopsy and the other
half were diagnosed either by opthalmoscopic
examination (4 cases) or echocardiogram (2 cases).
Two-thirds of these patients completed treatment and
the other 1/3 defaulted during treatment.
DISCUSSION
Over the last 2 decades, the incidence of
extrapulmonary tuberculosis in developed countries
has remained relatively constant, despite a progressive
fall in the number of reported cases of pulmonary
tuberculosis (Farer et al, 1979; Dwyer et al, 1987;
Rieder et al, 1990). Tuberculosis is still a major public
health problem in Malaysia. From this study, the
frequency distribution of extrapulmonary tuberculosis
was 10% for all cases of tuberculosis. This finding is
Table 3
Disease location of extra-pulmonary tuberculosis of
195 patients.
Disease location No. of patients (%)
Lymph node 83 (42.6)
Cervical 59 (30.3)
Supraclavicular 10 (5.1)
Axilla or mediastinal 5 (2.6)
Mixed 9 (4.6)
Miliary/disseminated 38 (19.5)
Pleura 25 (12.8)
Osteoarticular (bone/joint) 24 (12.3)
Spine 20 (10.3)
Hip 3 (1.5)
Knee 1 (0.5)
Genito-urinary tract 8 (4.1)
Bladder 4 (2.1)
Testes 2 (1.0)
Kidney 1 (0.5)
Ovary 1 (0.5)
Abdomen 6 (3.1)
Peritoneum 4 (2.1)
Intestine 1 (0.5)
Liver 1 (0.5)
Others 12 (6.2)
Eye 4 (2.1)
Skin 4 (2.1)
Heart 2 (1.0)
Breast 1 (0.5)
Skeletal muscle 1 (0.5)
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supported by previons reports (Mehta et al, 1991;
Hayati et al, 1993; Noertjojo et al, 2002; Sachdeva et
al, 2002), however, few other studies showed figures
higher than ours (Dolberg et al, 1991; Fernandez Jorge
et al, 1995; Denis-Delpierre et al, 1998; Lado Lado et
al, 2000). The variation in the rate of EPT could be
generally due to changes in the patients with
tuberculosis, the accuracy in term of early diagnosis,
and appropriate investigations and treatment.
Moreover, extrapulmonary tuberculosis rapidly
progresses by nature, and is potentially fatal but usually
treatable condition. Therefore, diagnostic procedures
should seek earlier detection in any suspected cases,
before final diagnosis.
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The demographic patterns of these patients clearly
showed that, for age distribution, extrapulmonary
tuberculosis is acquired in the early teens and tends to
increase with age (25-34 years), then decline as one
becomes older. The Malays were not only the major
ethnic group, but also had the highest frequency of
EPT-lymph node, miliary, pleura, and spine when
compared with the others in this study. Furthermore,
unfavorable social conditions, such as marital status,
unemployment, smoking and alcohol, intravenous drug
use, and history of previous exposure and contact with
tuberculosis showed similar results to other studies
(Fernandez Jorge et al, 1995; Fain et al, 2000). In this
context, we conclude that socio-demographic
differences are more important contributing factors to
the gradual increase in the course of disease.
In the majority of cases, the method of diagnosis
was histology (102/195; 52%), particularly in TB-
lymph node (68/83; 82%) in this study, not only to
confirm diagnosis but also to differentiate tuberculosis
from malignancy or other metastatic forms. We noted
that 84/195 (43%) of these patients had positive
tuberculin skin tests, which were also more common
in TB-lymph node (51/83; 62%). Therefore, we
concluded that tuberculin skin tests should be
performed on all individuals suspected of tuberculosis
which is supported by an earlier work (Elder, 1992),
but contrary to others (Yaacob, 1990; Qari, 2002). Even
though both sputum for smear and culture were
performed in most cases, positive results were not
encouraging; however, no relevant drug resistance was
found from culture and sensitivity testing. This study
showed that abnormalities by x-ray findings were
directly proportional to the number of sites involved.
Meanwhile, we should not dismiss extrapulmonary
tuberculosis, even in the case of normal x-ray findings.
Tuberculous lymphadenitis was the most common
extrapulmonary tuberculosis (43%) with predominant
cervical lymph node involvement and in females.
These findings are supported by previous studies (Tan,
1988; Shimoide et al, 1994; Huang et al, 2000; Chan-
Yeung et al, 2002; Ebdrup et al, 2003). However,
pleural tuberculosis was the most common, as found
in other studies (Haegi, 1987; Ramos et al,1995; Ozbay
and Uzun, 2002; El-Sony et al, 2003).
In general, the role of treatment in extrapulmonary
tuberculosis is as important as in pulmonary TB or
even greater. However, there have been comparatively
few clinical trials on the treatment of extrapulmonary
disease. Overall, 73% of these patients were
successfully treated with at least a short course of anti-
tubercular therapy and  without evidence of relapse.
This finding agrees with previous reports (Monie et
al, 1982; Dutt et al, 1986; Dutt and Stead, 1989).
Thirty-three percent of cases were treated for ≥ 9
months of ATT, which shows that patients appear to
be more compliant or adherent to therapy and
eventually can prevent the recurrence of tuberculosis.
Interestingly, we found that the 12-month courses of
ATT were practically given, as seen in the majority of
patients with osteoarticular tuberculosis, which was also
recommended by other investigators in the literature
(Newton et al, 1982; Pertuiset et al, 1999).
Unfortunately, 23% of all cases were lost to follow-up
before completing anti-tubercular therapy. Therefore,
we strongly recommend that measures should be adapted
for the therapeutic management of these patients (Fain
et al, 2000) in order to enhance the effectiveness of the
national tuberculosis control program.
Based on our findings, extrapulmonary tuber-
culosis is still gaining attention and has not yet
disappeared from Malaysia. Predisposing factors seem
to play contributing roles in the cause of disease. The
most common site of involvement was the lymph node,
followed by miliary and disseminated, pleura, skeleton,
genitourinary tract, abdomen and others, respectively.
The duration of treatment varied from 6 to 12 months,
depending on the site of involvement. No primary drug
resistance or death was notified in this study.
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